Managing inflammatory bowel disease at Sinai Health
Research shows that 1 in 150 Canadians have Inflammatory Bowel Disease or IBD, making Canada one of the countries with the highest prevalence rates in the world.
IBD, including Crohn’s disease and ulcerative colitis, is an umbrella term used to describe conditions that result in chronic inflammation of the gastrointestinal tract. Patients can experience debilitating pain, fatigue and unintentional weight loss, which causes a significant impact on quality of life.
The cause of IBD is currently unknown and there is no cure, but great strides have been made to understand the disease and, through medication and surgery, manage its symptoms.
Throughout February, we’ll highlight stories of world-leading care and research for Inflammatory Bowel Disease. You will hear from our researchers and front-line colleagues who work to improve the quality of life for patients with IBD.
- We are renowned for delivering excellence in patient care, education and research for patients with disorders of the gastrointestinal tract (esophagus, stomach, pancreas, liver, small intestine, and colon)
- Mount Sinai Hospital’s Centre for Inflammatory Bowel Disease serves over 4,700 patients annually, many from outside of Toronto and Ontario
- The Zane Cohen Centre for Digestive Diseases (ZCC) is internationally acclaimed as a clinical research facility in the understanding and treatment of gastrointestinal diseases
We are leaders
To learn more, stay tuned here and across our social media channels throughout the month and follow the hashtags #SinaiStories and #SinaiResearch.